Aspirin/Sumatriptan Succinate
阿司匹林/琥珀酸舒马普坦
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAspirin/Sumatriptan Succinate
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AspirinSumatriptan Succinate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivid Pharma
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A